Over the 90-day window ending December 12, 2025, Galectin Therapeutics's three dominant insider ownership positions are held by TenPercentOwner Fund, L.P. 10X (5.67Mn shares), President And CEO Joel Lewis (834.59K shares), Director Kevin D Freeman (129.77K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Richard E Uihlein | 10,301,271 | 27 Jan, 2025 | |
| James C Czirr | 5,922,207 | 25 Apr, 2024 | |
| Fund, L.P. 10X | 5,670,138 | 08 Dec, 2025 | |
| Joel Lewis | President And CEO | 834,592 | 19 Nov, 2025 |
| Kevin D Freeman | 129,769 | 18 Jul, 2025 | |
| Kary Eldred | 64,682 | 22 Jul, 2025 | |
| Gilbert F Amelio | 60,614 | 19 Jan, 2021 | |
| Richard A. Jr. Zordani | 44,083 | 26 Dec, 2024 | |
| Harold H. Shlevin | 11,206 | 10 Dec, 2025 | |
| Jack W Callicutt | Chief Financial Officer | 7,614 | 19 Nov, 2025 |
| Khurram Jamil | Chief Medical Officer | 4,479 | 14 Nov, 2025 |
| Elissa J. Schwartz | 1,000 | 24 Jan, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | D | 4,000 | $6.00 | 11,206 | D | S |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | A | 35,000 | $2.86 | 46,206 | D | M |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | D | 35,000 | $5.95 | 11,206 | D | S |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | A | 20,000 | $2.11 | 31,206 | D | M |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | D | 20,000 | $5.96 | 11,206 | D | S |
| 08 Dec, 2025 | Harold H. Shlevin | Common stock | A | 20,000 | $1.98 | 31,206 | D | M |
| 08 Dec, 2025 | Harold H. Shlevin | Common stock | D | 20,000 | $5.96 | 11,206 | D | S |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | A | 25,000 | $1.72 | 36,206 | D | M |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | D | 25,000 | $5.95 | 11,206 | D | S |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | A | 35,000 | $2.11 | 46,206 | D | M |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | D | 35,000 | $6.02 | 11,206 | D | S |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | A | 20,000 | $1.11 | 31,206 | D | M |
| 08 Dec, 2025 | Harold H. Shlevin | Common Stock | D | 20,000 | $6.00 | 11,206 | D | S |
| 09 Dec, 2025 | Harold H. Shlevin | Common Stock | A | 16,790 | $4.16 | 27,996 | D | M |
| 09 Dec, 2025 | Harold H. Shlevin | Common Stock | D | 16,790 | $6.27 | 11,206 | D | S |
| 02 Dec, 2025 | Fund, L.P. 10X | Common Stock | D | 30,000 | $5.47 | 5,802,207 | D | S |
| 02 Dec, 2025 | Fund, L.P. 10X | Common Stock | D | 30,000 | $5.47 | 5,802,207 | D | S |
| 03 Dec, 2025 | Fund, L.P. 10X | Common Stock | D | 120,000 | $5.73 | 5,682,207 | D | S |
| 03 Dec, 2025 | Fund, L.P. 10X | Common Stock | D | 132,069 | $5.73 | 5,670,138 | D | S |
| 17 Nov, 2025 | Joel Lewis | Common Stock | A | 15,680 | $2.39 | 848,272 | D | M |